Lafutidine: Revolutionizing Peptic Ulcer Treatment and Gastric Protection

Discover the advanced H2 receptor antagonist that offers superior mucosal protection and ulcer healing capabilities.

Get a Quote & Sample

Key Product Advantages

Superior Acid Inhibition

Lafutidine offers strong and long-lasting acid inhibition, significantly more potent than traditional H2 receptor antagonists, providing sustained relief from acid-related symptoms.

Enhanced Mucosal Defense

This compound actively promotes the production of mucin and bicarbonate, fortifying the gastric lining and creating a resilient barrier against acid damage.

Accelerated Ulcer Healing

Lafutidine demonstrates a remarkable ability to accelerate the healing of gastric mucosal damage, improving the quality of mucosal repair compared to other treatments.

Key Applications

Peptic Ulcer Disease Treatment

Lafutidine is a primary choice for treating peptic ulcer disease, promoting faster healing and reducing recurrence rates by effectively managing gastric acid.

Gastric Acid Inhibition

Its core function involves the potent inhibition of gastric acid secretion, offering relief for conditions aggravated by excess stomach acid.

Digestive Mucosa Protection

Beyond acid reduction, Lafutidine actively protects and enhances the integrity of the digestive mucosa, forming a crucial protective barrier.

Gastroesophageal Reflux Disease (GERD) Management

The drug's ability to reduce acid secretion makes it effective in managing symptoms associated with GERD and other acid-related gastrointestinal disorders.